Recommendations for medical management of adult lead exposure

Michael J. Kosnett, Richard P. Wedeen, Stephen J. Rothenberg, Karen L. Hipkins, Barbara L. Materna, Brian S Schwartz, Howard Hu, Alan Woolf

Research output: Contribution to journalArticle

Abstract

Research conducted in recent years has increased public health concern about the toxicity of lead at low dose and has supported a reappraisal of the levels of lead exposure that may be safely tolerated in the workplace. In this article, which appears as part of a mini-monograph on adult lead exposure, we summarize a body of published literature that establishes the potential for hypertension, effects on renal function, cognitive dysfunction, and adverse female reproductive outcome in adults with whole-blood lead concentrations <40 μg/dL. Based on this literature, and our collective experience in evaluating lead-exposed adults, we recommend that individuals be removed from occupational lead exposure if a single blood lead concentration exceeds 30 μg/dL or if two successive blood lead concentrations measured over a 4-week interval are ≥ 20 μg/dL. Removal of individuals from lead exposure should be considered to avoid long-term risk to health if exposure control measures over an extended period do not decrease blood lead concentrations to <10 μg/dL or if selected medical conditions exist that would increase the risk of continued exposure. Recommended medical surveillance for all lead-exposed workers should include quarterly blood lead measurements for individuals with blood lead concentrations between 10 and 19 μg/dL, and semiannual blood lead measurements when sustained blood lead concentrations are <10 μg/dL. It is advisable for pregnant women to avoid occupational or avocational lead exposure that would result in blood lead concentrations > 5 μg/dL. Chelation may have an adjunctive role in the medical management of highly exposed adults with symptomatic lead intoxication but is not recommended for asymptomatic individuals with low blood lead concentrations.

Original languageEnglish (US)
Pages (from-to)463-471
Number of pages9
JournalEnvironmental Health Perspectives
Volume115
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Blood
blood
hypertension
chelation
Public health
Chelation
workplace
Workplace
Toxicity
public health
Public Health
recommendation
exposure
Lead
toxicity
Hypertension
Kidney
Research
intoxication
effect

Keywords

  • Adult lead exposure
  • Blood lead
  • Chelation
  • Medical management
  • Medical surveillance
  • Pregnancy

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Public Health, Environmental and Occupational Health

Cite this

Kosnett, M. J., Wedeen, R. P., Rothenberg, S. J., Hipkins, K. L., Materna, B. L., Schwartz, B. S., ... Woolf, A. (2007). Recommendations for medical management of adult lead exposure. Environmental Health Perspectives, 115(3), 463-471. https://doi.org/10.1289/ehp.9784

Recommendations for medical management of adult lead exposure. / Kosnett, Michael J.; Wedeen, Richard P.; Rothenberg, Stephen J.; Hipkins, Karen L.; Materna, Barbara L.; Schwartz, Brian S; Hu, Howard; Woolf, Alan.

In: Environmental Health Perspectives, Vol. 115, No. 3, 03.2007, p. 463-471.

Research output: Contribution to journalArticle

Kosnett, MJ, Wedeen, RP, Rothenberg, SJ, Hipkins, KL, Materna, BL, Schwartz, BS, Hu, H & Woolf, A 2007, 'Recommendations for medical management of adult lead exposure', Environmental Health Perspectives, vol. 115, no. 3, pp. 463-471. https://doi.org/10.1289/ehp.9784
Kosnett MJ, Wedeen RP, Rothenberg SJ, Hipkins KL, Materna BL, Schwartz BS et al. Recommendations for medical management of adult lead exposure. Environmental Health Perspectives. 2007 Mar;115(3):463-471. https://doi.org/10.1289/ehp.9784
Kosnett, Michael J. ; Wedeen, Richard P. ; Rothenberg, Stephen J. ; Hipkins, Karen L. ; Materna, Barbara L. ; Schwartz, Brian S ; Hu, Howard ; Woolf, Alan. / Recommendations for medical management of adult lead exposure. In: Environmental Health Perspectives. 2007 ; Vol. 115, No. 3. pp. 463-471.
@article{d19952848fe04a54b7ca8989092f717e,
title = "Recommendations for medical management of adult lead exposure",
abstract = "Research conducted in recent years has increased public health concern about the toxicity of lead at low dose and has supported a reappraisal of the levels of lead exposure that may be safely tolerated in the workplace. In this article, which appears as part of a mini-monograph on adult lead exposure, we summarize a body of published literature that establishes the potential for hypertension, effects on renal function, cognitive dysfunction, and adverse female reproductive outcome in adults with whole-blood lead concentrations <40 μg/dL. Based on this literature, and our collective experience in evaluating lead-exposed adults, we recommend that individuals be removed from occupational lead exposure if a single blood lead concentration exceeds 30 μg/dL or if two successive blood lead concentrations measured over a 4-week interval are ≥ 20 μg/dL. Removal of individuals from lead exposure should be considered to avoid long-term risk to health if exposure control measures over an extended period do not decrease blood lead concentrations to <10 μg/dL or if selected medical conditions exist that would increase the risk of continued exposure. Recommended medical surveillance for all lead-exposed workers should include quarterly blood lead measurements for individuals with blood lead concentrations between 10 and 19 μg/dL, and semiannual blood lead measurements when sustained blood lead concentrations are <10 μg/dL. It is advisable for pregnant women to avoid occupational or avocational lead exposure that would result in blood lead concentrations > 5 μg/dL. Chelation may have an adjunctive role in the medical management of highly exposed adults with symptomatic lead intoxication but is not recommended for asymptomatic individuals with low blood lead concentrations.",
keywords = "Adult lead exposure, Blood lead, Chelation, Medical management, Medical surveillance, Pregnancy",
author = "Kosnett, {Michael J.} and Wedeen, {Richard P.} and Rothenberg, {Stephen J.} and Hipkins, {Karen L.} and Materna, {Barbara L.} and Schwartz, {Brian S} and Howard Hu and Alan Woolf",
year = "2007",
month = "3",
doi = "10.1289/ehp.9784",
language = "English (US)",
volume = "115",
pages = "463--471",
journal = "Environmental Health Perspectives",
issn = "0091-6765",
publisher = "Public Health Services, US Dept of Health and Human Services",
number = "3",

}

TY - JOUR

T1 - Recommendations for medical management of adult lead exposure

AU - Kosnett, Michael J.

AU - Wedeen, Richard P.

AU - Rothenberg, Stephen J.

AU - Hipkins, Karen L.

AU - Materna, Barbara L.

AU - Schwartz, Brian S

AU - Hu, Howard

AU - Woolf, Alan

PY - 2007/3

Y1 - 2007/3

N2 - Research conducted in recent years has increased public health concern about the toxicity of lead at low dose and has supported a reappraisal of the levels of lead exposure that may be safely tolerated in the workplace. In this article, which appears as part of a mini-monograph on adult lead exposure, we summarize a body of published literature that establishes the potential for hypertension, effects on renal function, cognitive dysfunction, and adverse female reproductive outcome in adults with whole-blood lead concentrations <40 μg/dL. Based on this literature, and our collective experience in evaluating lead-exposed adults, we recommend that individuals be removed from occupational lead exposure if a single blood lead concentration exceeds 30 μg/dL or if two successive blood lead concentrations measured over a 4-week interval are ≥ 20 μg/dL. Removal of individuals from lead exposure should be considered to avoid long-term risk to health if exposure control measures over an extended period do not decrease blood lead concentrations to <10 μg/dL or if selected medical conditions exist that would increase the risk of continued exposure. Recommended medical surveillance for all lead-exposed workers should include quarterly blood lead measurements for individuals with blood lead concentrations between 10 and 19 μg/dL, and semiannual blood lead measurements when sustained blood lead concentrations are <10 μg/dL. It is advisable for pregnant women to avoid occupational or avocational lead exposure that would result in blood lead concentrations > 5 μg/dL. Chelation may have an adjunctive role in the medical management of highly exposed adults with symptomatic lead intoxication but is not recommended for asymptomatic individuals with low blood lead concentrations.

AB - Research conducted in recent years has increased public health concern about the toxicity of lead at low dose and has supported a reappraisal of the levels of lead exposure that may be safely tolerated in the workplace. In this article, which appears as part of a mini-monograph on adult lead exposure, we summarize a body of published literature that establishes the potential for hypertension, effects on renal function, cognitive dysfunction, and adverse female reproductive outcome in adults with whole-blood lead concentrations <40 μg/dL. Based on this literature, and our collective experience in evaluating lead-exposed adults, we recommend that individuals be removed from occupational lead exposure if a single blood lead concentration exceeds 30 μg/dL or if two successive blood lead concentrations measured over a 4-week interval are ≥ 20 μg/dL. Removal of individuals from lead exposure should be considered to avoid long-term risk to health if exposure control measures over an extended period do not decrease blood lead concentrations to <10 μg/dL or if selected medical conditions exist that would increase the risk of continued exposure. Recommended medical surveillance for all lead-exposed workers should include quarterly blood lead measurements for individuals with blood lead concentrations between 10 and 19 μg/dL, and semiannual blood lead measurements when sustained blood lead concentrations are <10 μg/dL. It is advisable for pregnant women to avoid occupational or avocational lead exposure that would result in blood lead concentrations > 5 μg/dL. Chelation may have an adjunctive role in the medical management of highly exposed adults with symptomatic lead intoxication but is not recommended for asymptomatic individuals with low blood lead concentrations.

KW - Adult lead exposure

KW - Blood lead

KW - Chelation

KW - Medical management

KW - Medical surveillance

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=34147120291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147120291&partnerID=8YFLogxK

U2 - 10.1289/ehp.9784

DO - 10.1289/ehp.9784

M3 - Article

C2 - 17431500

AN - SCOPUS:34147120291

VL - 115

SP - 463

EP - 471

JO - Environmental Health Perspectives

JF - Environmental Health Perspectives

SN - 0091-6765

IS - 3

ER -